3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
46
Phase 1
38
Phase 1/2
21
Phase EARLY_PHASE1
2
Phase 3
2
Phase 4
1
Status
Completed
3
Recruiting
2
Terminated
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Skin Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Interventions
Saline Solution
6
Fentanyl
6
Sodium Chloride
5
Letrozole
5
Dexamethasone
5
Pregabalin
4
Ketamine
4
Goserelin
4
Gemcitabine
4
Bevacizumab
4
Tranexamic Acid
3
Photochemotherapy
3
Pemetrexed
3
Paclitaxel
3
Metformin
3
Leuprolide
3
Docetaxel
3
Cyclophosphamide
3
Carboplatin
3
Capecitabine
3
Acetaminophen
3
ulipristal acetate
2
sodium glycididazole
2
nilotinib
2
liposomal doxorubicin
2
human papillomavirus vaccine, L1 type 16, 18
2
flurbiprofen axetil
2
fludarabine
2
fluciclovine F-18
2
epoetin beta
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Terminated
×
Ipilimumab
×
Clear all
NCT01856023
2023-12-05
PROCLIVITY02
Clinigen, Inc.
Phase 4
Terminated
29 enrolled
9 charts